278 related articles for article (PubMed ID: 12553057)
1. Induction of N-myc in neuroblastoma by autocrine IGF-II depends on farnesylated Ras. Application of farnesyltransferase inhibitors.
Wittrock J; Schweizer P; Girgert R
Anticancer Res; 2002; 22(6C):4205-9. PubMed ID: 12553057
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma: inhibition of progression (Part II). Basic science in pediatric surgery.
Girgert R; Wittrock J; Schweizer P
Eur J Pediatr Surg; 2001 Dec; 11(6):363-7. PubMed ID: 11807663
[TBL] [Abstract][Full Text] [Related]
3. Farnesyltransferase inhibitor FTI-277 prevents autocrine growth stimulation of neuroblastoma by BDNF.
Girgert R; Wittrock J; Pfister S; Schweizer P
J Cancer Res Clin Oncol; 2003 Apr; 129(4):227-33. PubMed ID: 12700894
[TBL] [Abstract][Full Text] [Related]
4. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
[TBL] [Abstract][Full Text] [Related]
5. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
7. c-myc down-regulation induces apoptosis in human cancer cell lines exposed to RPR-115135 (C31H29NO4), a non-peptidomimetic farnesyltransferase inhibitor.
Russo P; Arzani D; Trombino S; Falugi C
J Pharmacol Exp Ther; 2003 Jan; 304(1):37-47. PubMed ID: 12490573
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
[TBL] [Abstract][Full Text] [Related]
9. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.
El-Badry OM; Romanus JA; Helman LJ; Cooper MJ; Rechler MM; Israel MA
J Clin Invest; 1989 Sep; 84(3):829-39. PubMed ID: 2547840
[TBL] [Abstract][Full Text] [Related]
10. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts.
Sun J; Qian Y; Hamilton AD; Sebti SM
Oncogene; 1998 Mar; 16(11):1467-73. PubMed ID: 9525745
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of farnesyltransferase increases TGFbeta type II receptor expression and enhances the responsiveness of human cancer cells to TGFbeta.
Adnane J; Bizouarn FA; Chen Z; Ohkanda J; Hamilton AD; Munoz-Antonia T; Sebti SM
Oncogene; 2000 Nov; 19(48):5525-33. PubMed ID: 11114730
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of farnesyl-protein-transferase in neuroblastoma cells by alpha-hydroxyfarnesylphosphonate.
Girgert R; Hohnecker A; Wittrock J; Schweizer P
Anticancer Res; 1999; 19(4B):2959-62. PubMed ID: 10652579
[TBL] [Abstract][Full Text] [Related]
13. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
[TBL] [Abstract][Full Text] [Related]
14. Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells.
Morgan MA; Sebil T; Aydilek E; Peest D; Ganser A; Reuter CW
Br J Haematol; 2005 Sep; 130(6):912-25. PubMed ID: 16156861
[TBL] [Abstract][Full Text] [Related]
15. Farnesyltransferase inhibitors reverse Ras-mediated inhibition of Fas gene expression.
Zhang B; Prendergast GC; Fenton RG
Cancer Res; 2002 Jan; 62(2):450-8. PubMed ID: 11809695
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of IGF-II-induced IL-8 by extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinases in human keratinocytes.
Kim HJ; Byun SJ; Kim TY
Biochem Biophys Res Commun; 2004 Apr; 317(1):276-84. PubMed ID: 15047180
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I induction of c-myc expression in bovine fibroblasts can be blocked by antecedent insulin receptor activation.
Conover CA; Bale LK
Exp Cell Res; 1998 Jan; 238(1):122-7. PubMed ID: 9457064
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma.
Ren Y; Chan HM; Li Z; Lin C; Nicholls J; Chen CF; Lee PY; Lui V; Bacher M; Tam PK
Oncogene; 2004 May; 23(23):4146-54. PubMed ID: 15064733
[TBL] [Abstract][Full Text] [Related]
19. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes, differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C.
Kim HJ; Kim TY
Br J Dermatol; 2005 Mar; 152(3):418-25. PubMed ID: 15787809
[TBL] [Abstract][Full Text] [Related]
20. A farnesyltransferase inhibitor attenuates cardiac myocyte hypertrophy and gene expression.
Calderone A; Abdelaziz N; Colombo F; Schreiber KL; Rindt H
J Mol Cell Cardiol; 2000 Jun; 32(6):1127-40. PubMed ID: 10888263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
